Teva- Pharmaceutical Industries Ltd

NYSE: TEVA
$17.37
-$1.41 (-7.5%)
Real Time Data Delayed 15 Min.

TEVA Articles

The November 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The November 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased, with one major exception.
The demand for drugs to treat erectile dysfunction has risen to meet the needs of an aging population and to help combat disease-related causes.
The top analyst upgrades, downgrades and initiations seen on Monday included Adamas Pharmaceuticals, Alibaba, Bluebird Bio, Chevron, Encana, Parsley Energy, Starbucks, Teva Pharmaceutical and Under...
Teva Pharmaceutical released its most recent earnings report before the markets opened on Thursday.
We are in the midst of earnings season, during which most major companies will report and set a direction for the market. We have included the consensus earnings estimates from Thomson Reuters and...
The October 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The September 28 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks decreased.
The top analyst upgrades, downgrades and initiations seen on Monday included Amgen, Chipotle Mexican Grill, Lam Research, Netgear, Teva Pharmaceutical and Western Digital.
The September 14 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Teva Pharmaceuticals shares made a solid gain on Monday morning after the company announced a critical approval by the FDA.
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in September.
The top analyst upgrades, downgrades and initiations seen on Friday include Apple, Caterpillar, Costco, GW Pharmaceuticals, NXP Semiconductors, Southwest Airlines, Teva Pharmaceutical, Ulta Beauty...